Publications by authors named "Hiroyuki Inuzuka"

83Publications

Phosphorylation-dependent osterix degradation negatively regulates osteoblast differentiation.

FASEB J 2020 Nov 15;34(11):14930-14945. Epub 2020 Sep 15.

Center for Advanced Stem Cell and Regenerative Research, Tohoku University Graduate School of Dentistry, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.202001340RDOI Listing
November 2020

G protein-coupled receptor () is required for enamel mineralization mediated by ameloblasts.

J Biol Chem 2020 Nov 31;295(45):15328-15341. Epub 2020 Aug 31.

Division of Pediatric Dentistry, Department of Oral Health and Development Sciences, Tohoku University Graduate School of Dentistry, Sendai, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.RA120.014281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650236PMC
November 2020

Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ.

iScience 2020 Jul 30;23(7):101329. Epub 2020 Jun 30.

Division of Pediatric Dentistry, Department of Oral Health and Development Sciences, Tohoku University Graduate School of Dentistry, Sendai 980-8575, Japan; Center for Advanced Stem Cell and Regenerative Research, Tohoku University Graduate School of Dentistry, Sendai 980-8575, Japan; Section of Pediatric Dentistry, Division of Oral Health, Growth and Development, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.isci.2020.101329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363706PMC
July 2020

Lipin-2 degradation elicits a proinflammatory gene signature in macrophages.

Biochem Biophys Res Commun 2020 04 31;524(2):477-483. Epub 2020 Jan 31.

Center for Advanced Stem Cell and Regenerative Research, Tohoku University Graduate School of Dentistry, Sendai, 980-8575, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2020.01.119DOI Listing
April 2020

SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation.

Mol Oncol 2019 02 3;13(2):307-321. Epub 2018 Dec 3.

Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/1878-0261.12403
Publisher Site
http://dx.doi.org/10.1002/1878-0261.12403DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360357PMC
February 2019

SCF-mediated degradation of Brg1 suppresses gastric cancer metastasis.

Nat Commun 2018 09 3;9(1):3569. Epub 2018 Sep 3.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41467-018-06038-y
Publisher Site
http://dx.doi.org/10.1038/s41467-018-06038-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120942PMC
September 2018

Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.

Sci Signal 2018 03 13;11(521). Epub 2018 Mar 13.

Department of Pathology, Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aao3810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902813PMC
March 2018

SCF E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation.

Protein Cell 2018 10 1;9(10):879-889. Epub 2018 Mar 1.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13238-018-0510-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160385PMC
October 2018

Physiological functions of FBW7 in cancer and metabolism.

Cell Signal 2018 06 21;46:15-22. Epub 2018 Feb 21.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2018.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882551PMC
June 2018

Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.

Sci Signal 2017 02 14;10(466). Epub 2017 Feb 14.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aai8026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468793PMC
February 2017

EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor.

Oncotarget 2017 Jan;8(4):6787-6795

Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/14290
Publisher Site
http://dx.doi.org/10.18632/oncotarget.14290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351669PMC
January 2017

SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage.

Nucleic Acids Res 2016 Oct 26;44(18):8855-8869. Epub 2016 Aug 26.

Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08903, USA Department of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08903-0019, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkw748DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062998PMC
October 2016

Smurf1 regulation of DAB2IP controls cell proliferation and migration.

Oncotarget 2016 May;7(18):26057-69

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041964PMC
May 2016

SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation.

Nat Commun 2015 Dec 15;6:10185. Epub 2015 Dec 15.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms10185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682171PMC
December 2015

SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression.

Mol Cell 2015 Sep 3;59(6):917-30. Epub 2015 Sep 3.

Department of Pathology, Cancer Research Institute, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2015.07.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575912PMC
September 2015

SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.

Mol Cell 2014 Nov 30;56(4):595-607. Epub 2014 Oct 30.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2014.09.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255362PMC
November 2014

Acetylation-dependent regulation of essential iPS-inducing factors: a regulatory crossroad for pluripotency and tumorigenesis.

Cancer Med 2014 Oct 13;3(5):1211-24. Epub 2014 Aug 13.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302671PMC
October 2014

SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination.

Oncotarget 2014 Jun;5(12):4211-21

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147317PMC
http://dx.doi.org/10.18632/oncotarget.1971DOI Listing
June 2014

SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation.

Am J Cancer Res 2014 26;4(3):245-55. Epub 2014 May 26.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School Boston, MA 02215, USA ; State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences 320 Yue-Yang Road, Shanghai 200031, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065405PMC
June 2014

Negative regulation of DAB2IP by Akt and SCFFbw7 pathways.

Oncotarget 2014 May;5(10):3307-15

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102811PMC
http://dx.doi.org/10.18632/oncotarget.1939DOI Listing
May 2014

APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.

Dev Cell 2014 May;29(4):377-91

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.devcel.2014.04.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081014PMC
May 2014

Roles of F-box proteins in cancer.

Nat Rev Cancer 2014 Apr;14(4):233-47

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306233PMC
April 2014

SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.

Oncotarget 2014 Feb;5(4):1026-37

Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology and Frontier Institute of Life Science, FIST, Xi'an Jiaotong University, Xi'an, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011580PMC
http://dx.doi.org/10.18632/oncotarget.1675DOI Listing
February 2014

SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression.

Cell Rep 2013 Aug 22;4(4):803-16. Epub 2013 Aug 22.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2013.07.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839583PMC
August 2013

Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7.

Cell Res 2013 Jul 14;23(7):947-61. Epub 2013 May 14.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cr.2013.67DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698637PMC
July 2013

Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis.

Discov Med 2013 Jan;15(80):7-15

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522964PMC
January 2013

DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase.

Mol Cell Biol 2013 Mar 7;33(6):1139-48. Epub 2013 Jan 7.

Laboratory of Epigenetics, Institute of Biomedical Sciences, and Department of Biochemistry, Fudan University Medical School, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.01191-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592027PMC
March 2013

Cdc20: a potential novel therapeutic target for cancer treatment.

Curr Pharm Des 2013 ;19(18):3210-4

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014638PMC
http://dx.doi.org/10.2174/1381612811319180005DOI Listing
October 2013

DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction.

Oncotarget 2012 Sep;3(9):1026-35

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660052PMC
http://dx.doi.org/10.18632/oncotarget.640DOI Listing
September 2012

An evolving role for DEPTOR in tumor development and progression.

Neoplasia 2012 May;14(5):368-75

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384424PMC
http://dx.doi.org/10.1593/neo.12542DOI Listing
May 2012

Tumor suppressor functions of FBW7 in cancer development and progression.

FEBS Lett 2012 May 21;586(10):1409-18. Epub 2012 Mar 21.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2012.03.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372850PMC
May 2012

DEPTOR ubiquitination and destruction by SCF(β-TrCP).

Am J Physiol Endocrinol Metab 2012 Jul 27;303(2):E163-9. Epub 2012 Mar 27.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpendo.00105.2012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431131PMC
July 2012

Skp2 is a promising therapeutic target in breast cancer.

Front Oncol 2012 Jan;1(57)

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fonc.2011.000
Publisher Site
http://dx.doi.org/10.3389/fonc.2011.00057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263529PMC
January 2012

Emerging roles of the FBW7 tumour suppressor in stem cell differentiation.

EMBO Rep 2011 Dec 23;13(1):36-43. Epub 2011 Dec 23.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/embor.2011.231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246256PMC
December 2011

The two faces of FBW7 in cancer drug resistance.

Bioessays 2011 Nov 30;33(11):851-9. Epub 2011 Aug 30.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bies.201100101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364519PMC
November 2011

Skp2: a novel potential therapeutic target for prostate cancer.

Biochim Biophys Acta 2012 Jan 22;1825(1):11-7. Epub 2011 Sep 22.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2011.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242930PMC
January 2012

Mcl-1 ubiquitination and destruction.

Oncotarget 2011 Mar;2(3):239-44

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/242
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260810PMC
http://dx.doi.org/10.18632/oncotarget.242DOI Listing
March 2011

Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction.

Oncotarget 2010 Nov;1(7):685-90

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248122PMC
http://dx.doi.org/10.18632/oncotarget.101011DOI Listing
November 2010

Akt finds its new path to regulate cell cycle through modulating Skp2 activity and its destruction by APC/Cdh1.

Cell Div 2009 Jun 23;4:11. Epub 2009 Jun 23.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1747-1028-4-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708142PMC
June 2009

Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways.

Mol Biol Cell 2009 Jul 28;20(14):3305-16. Epub 2009 May 28.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1091/mbc.e09-01-0092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710831PMC
July 2009

Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.

Nat Cell Biol 2009 Apr 8;11(4):397-408. Epub 2009 Mar 8.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncb1847
Publisher Site
http://dx.doi.org/10.1038/ncb1847DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910589PMC
April 2009

Experimental approaches to investigate the proteasomal degradation pathways involved in regulation of apoptosis.

Methods Enzymol 2008 ;446:205-23

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0076-6879(08)01612-1DOI Listing
August 2008

The PDZ scaffold NHERF-2 interacts with mGluR5 and regulates receptor activity.

J Biol Chem 2006 Oct 4;281(40):29949-61. Epub 2006 Aug 4.

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M602262200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670778PMC
October 2006

Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins.

J Biol Chem 2006 Feb 29;281(5):2820-7. Epub 2005 Nov 29.

Department of Biochemistry and Molecular Biology, Capital University of Medical Sciences, Beijing 100054, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M509503200DOI Listing
February 2006

Phosphorylation of Numb family proteins. Possible involvement of Ca2+/calmodulin-dependent protein kinases.

J Biol Chem 2005 Oct 16;280(42):35108-18. Epub 2005 Aug 16.

Department of Signal Transduction Sciences, Faculty of Medicine, Kagawa University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M503912200
Publisher Site
http://dx.doi.org/10.1074/jbc.M503912200DOI Listing
October 2005

Role of calcium-calmodulin-dependent protein kinase cascade in thyrotropin (TSH)-releasing hormone induction of TSH and prolactin gene expression.

Endocrinology 2004 Nov 12;145(11):4846-52. Epub 2004 Aug 12.

First Department of Internal Medicine, Faculty of Medicine, Kagawa University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2004-0544DOI Listing
November 2004

Mechanism of the generation of autonomous activity of Ca2+/calmodulin-dependent protein kinase IV.

J Biol Chem 2004 Sep 15;279(39):40296-302. Epub 2004 Jul 15.

Department of Signal Transduction Sciences, Faculty of Medicine, Kagawa University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M406534200DOI Listing
September 2004

Regulatory mechanism of Dictyostelium myosin light chain kinase A.

J Biol Chem 2004 Jan 21;279(1):42-50. Epub 2003 Oct 21.

Department of Signal Transduction Sciences, Kagawa Medical University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M309621200DOI Listing
January 2004

Identification and characterization of novel components of a Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells.

FEBS Lett 2003 Aug;550(1-3):57-63

Department of Signal Transduction Sciences, Kagawa Medical University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(03)00817-2DOI Listing
August 2003

A single amino acid difference between alpha and beta Ca2+/calmodulin-dependent protein kinase kinase dictates sensitivity to the specific inhibitor, STO-609.

J Biol Chem 2003 Mar 22;278(13):10908-13. Epub 2003 Jan 22.

Department of Signal Transduction Sciences, Kagawa Medical University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M213183200
Publisher Site
http://dx.doi.org/10.1074/jbc.M213183200DOI Listing
March 2003

Transcriptional regulation of nuclear orphan receptor, NOR-1, by Ca(2+)/calmodulin-dependent protein kinase cascade.

FEBS Lett 2002 Jul;522(1-3):88-92

Department of Chemistry, Kagawa Medical University, 1750-1 Miki-cho, Kita-gun, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(02)02890-9DOI Listing
July 2002

STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.

J Biol Chem 2002 May 26;277(18):15813-8. Epub 2002 Feb 26.

Department of Chemistry, Kagawa Medical University, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M201075200DOI Listing
May 2002